97123 ⎘
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
MUTANT FRAGMENTS OF OSPA AND METHODS AND USES RELATING THERETO
#2BORRELIA BURGDORFERI PEPTIDOGLYCAN DETECTION METHODS
#3LEPTOSPIRAL VIRULENCE MODULATING PROTEINS AND USES THEREOF
#4SEPTAPEPTIDES ASSOCIATED WITH NEURODEGENERACY
#5METHODS OF TREATING INFECTIONS BY BLOCKING PATHOGEN MIMICS OF CD47
#6MUTANT FRAGMENTS OF OSPA AND METHODS AND USES RELATING THERETO
#7MUTANT FRAGMENTS OF OSPA AND METHODS AND USES RELATING THERETO
#8TARGETING NAPA-LINKED PEPTIDOGLYCAN FOR TREATING LYME DISEASE
#9Mutant fragments of OspA and methods and uses relating thereto
#10USE OF MODIFIED HIV-1 FOR GENERATING FULLY HUMAN ANTIBODIES
#11SEPTAPEPTIDES ASSOCIATED WITH NEURODEGENERACY
#12Mutant fragments of OspA and methods and uses relating thereto
#13Mutant fragments of OspA and methods and uses relating thereto
#14DNA ANTIBODY CONSTRUCTS FOR USE AGAINST LYME DISEASE
#15Generation of human anti-HIV-1 ENV monoclonal antibodies with neutralizing activity from humanized mice infected with HIV-1
#16Mutant fragments of OspA and methods and uses relating thereto
#17Mutant fragments of OspA and methods and uses relating thereto
#18Polyvalent chimeric OspC vaccinogen and diagnostic antigen
#19PROTEINS WITH REPETITIVE BACTERIAL-IG-LIKE (BIG) DOMAINS PRESENT IN LEPTOSPIRA SPECIES
#20Anti-OSPA antibodies and methods of use
#21Lyme disease vaccine
#22Mutant fragments of OspA and methods and uses relating thereto
#23Proteins with repetitive bacterial-IG-like (Big) domains present in species
#24Mutant fragments of OspA and methods and uses relating thereto
#25VMP-LIKE SEQUENCES OF PATHOGENIC BORRELIA
#26MUTANT FRAGMENTS OF OspA AND METHODS AND USES RELATING THERETO
#27Polyvalent chimeric OSPC vaccinogen and diagnostic antigen
#28DIAGNOSTIC KIT FOR THE DETECTION OF EARLY ACUTE LEPTOSPIROSIS
#29Isolated Brachyspira and Methods and Compositions for Expanding and Isolating Brachyspira
#30Methods and compositions for reducing microorganisms in the oropharynx, nasopharynx and oral cavities
#31RECOMBINANT PROTEINS FOR USE IN VACCINE, ANTIBODIES AGAINST SAID PROTEINS, AND DIAGNOSTIC AND THERAPEUTIC METHODS INCLUDING THE SAME
#32Lyme disease vaccine
#33Compositions comprising chimeric OSPA molecules and methods of use thereof
#34Polyvalent chimeric OspC vaccinogen and diagnostic antigen
#35Vmp-like sequences of pathogenic
#36Proteins with repetitive bacterial-Ig-like (Big) domains present in species
#37VMP-like sequences of pathogenic
#38Proteins with repetitive Bacterial-Ig-like (Big) domains present in species
#39Proteins with repetitive bacterial-Ig-like (Big) domains present in species
#40LYME DISEASE VACCINE
#41Proteins with repetitive Bacterial-Ig-like (Big) domains present in species
#42NOVEL SEQUENCES OF BRACHYSPIRA, IMMUNOGENIC COMPOSITIONS, METHODS FOR PREPARATION AND USE THEREOF
#43Characterization of BBK07 antigen of and methods of use
#44VMP-like sequences of pathogenic
#45NOVEL GENES AND PROTEINS OF BRACHYSPIRA HYODYSENTERIAE AND USE OF SAME FOR DIAGNOSIS AND THERAPY
#46Proteins with repetitive Bacterial-Ig-like (Big) domains present in species
#47GENERATION OF SPECIFIC ADHESION IN GRAM-NEGATIVE BACTERIA BY MEANS OF ANCHORING IMMUNOGLOBULIN SINGLE DOMAINS ON THEIR SURFACE WITH AUTOTRANSPORTERS
#48Peptides for preventing, diagnosing and treating animal and/or human leptospirosis
#49VMP-like sequences of pathogenic
#50Proteins with repetitive bacterial-Ig-like (big) domains present in species
#51Recombinant constructs of
#52Preparation method of igy for preventing and cure mouth disease and the toothpaste base on the igy
#53Recombinant constructs of
#54Optical recording apparatus using one-dimensional diffractive light modulator
#55Immunotherapy for lyme disease